Scientists develop artificial chemical receptor to assist viral transduction for T cell engineering
(PHYSorg.com Chemistry)

Engineered T cell immunotherapy, such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy, has emerged as a potent therapeutic strategy for treating tumors.